Portfolio

AIRNA

CEO Kristian Elverum

AIRNA is transforming lives one RNA edit at a time

AIRNA is on a mission to transform the lives of patients with rare and common diseases by pioneering the discovery and development of RNA editing therapeutics.

AIRNA’s powerful and flexible RNA editing platform, RESTORE+™, is designed to restore a patient’s health by creating genetic medicines for rare and common diseases. RESTORE+™ is a systematic advancement of the first published ADAR platform developed by AIRNA’s founders, created to maximize therapeutic properties and address novel targets.

Human Health

AIRNA Bio Germany GmbH, Tübingen:
Rosentalstrasse 5
72070 Tuebingen

airna.com

Industry

Biotech

Status

Current

Location

Germany

AIRNA’s vision for leadership in RNA editing therapeutics is driven by leading science, a world-class team, and a focus on execution. Forbion has been an ideal partner to accelerate our journey through their strategic collaboration, distinctive network, and long-term commitment.

Kristian Elverum

CEO of AIRNA